(KEI blogs and other work on COVID-19 are here: https://www.keionline.org/coronavirus) A letter from Costa Rica, signed by Carlos Alarado Quesada, the President, and Dr. Daniel Salas Peraza, the Minister of Health, to Dr. Tedros Adhanom Ghebreyesus, was sent this evening… Continue Reading
Today the FDA granted Gilead Orphan Drug status for remdesivir for the treatment of COVID-19, on grounds this is a rare disease. The morning of the designation, the U.S. had confirmed, through testing, more than 35 thousand cases, including 8,477… Continue Reading
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. As the US and other governments begin to expend large amounts of money on research and development related to the control, prevention and treatment of the coronavirus pandemic, there are important… Continue Reading
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. The “Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020’’ will provide welcome funding to deal with the expanding COVID-19 pandemic. The current language on affordability (this Draft text), however, is worse… Continue Reading
Filed in 84 FR 68128, Docket No. 191126-0092. KEI-NIST-RFC-iEdison, 27Jan2020 January 27, 2020 Dr. Courtney Silverthorn Deputy Director, Technology Partnerships Office, National Institute of Standards and Technology Technology Partnerships Office 100 Bureau Drive, MS 2200, Gaithersburg, MD 20899, mailto:courtney.silverthorn@nist.gov Re:… Continue Reading
Joint Comments Regarding “Prospective Grant of an Exclusive Patent License: Development and Commercialization of CD19/CD22 Chimeric Antigen Receptor (CAR) Therapies for the Treatment of B-Cell Malignancies[,]” 85 FR 328 On January 21, 2020 five groups and two individuals filed comments… Continue Reading
This is the KEI request to appear at the January 30, 2020, USTR public hearing on petitions from the IIPA to impose higher tariffs (revoke GSP benefits) on South Africa and Indonesia over copyright issues. The docket is here: https://www.regulations.gov/document?D=USTR-2019-0020-0001… Continue Reading
KEI filed these comments on the NIH Draft Policy for Data Management and Sharing and Supplemental DRAFT Guidance January 10, 2019 1621 Connecticut Avenue NW Suite 500 Washington, DC 20009 www.keionline.org January 10, 2020 Office of Science Policy National Institutes… Continue Reading
KEI Comments on Intellectual Property Protection for Artificial Intelligence Innovation, for USPTO Request for Comments Re: 84 FR 66176, Docket No. PTO-C-2019-0038 10 January 2020 1. Should a work produced by an AI algorithm or process, without the involvement of… Continue Reading
SCCR39-broadcasting-treaty-NGO letter-23Oct2019 23 October 2019 Re: Objections to the Proposed WIPO Broadcasting Treaty Dear delegates to SCCR 39, We oppose the Chair’s proposal for a broadcast treaty. The proposal would give broadcasters effectively perpetual rights over content that they do… Continue Reading